Dr Kam Lally, skincare retailer co-owner Paul Thompson and chemical engineer Cigdem Kemal Yilmaz outline a strong retail strategy for clinic growth
A total of 7.7 million people had an aesthetic treatment in the UK in the past 12 months, with a further 13.9 million considering treatment within the next 12 months.¹ Although the UK aesthetics sector remains predominantly treatment-driven (with data suggesting injectables account for as much as 65% of total clinic revenue), retail represents a significant yet underexploited growth area.²⁻⁴
The UK professional skincare market is valued at around £1.2 billion and is growing, driven by increasing demand for high-quality, effective and professional-grade products.⁵ One study involving 13,377 individuals found that patients who purchased skincare products generated more revenue from both non-surgical and surgical treatments over time – in comparison to those who did not, suggesting skincare as an important adjunct to the clinic offering.⁶ Other data indicates that repeat patients spend up…
